Clinical Trials in Trondheim, Norway
1 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Eli Lilly and Company1,264 enrolled424 locationsNCT06119581
Recruiting
Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
AstraZeneca860 enrolled264 locationsNCT05211895
Recruiting
Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
Lung CancerArtificial IntelligenceEndobronchial Ultrasound
Norwegian University of Science and Technology50 enrolled2 locationsNCT05739331
Recruiting
Not Applicable
TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
Breast Neoplasm Malignant Primary
Norwegian University of Science and Technology250 enrolled1 locationNCT06310330
Recruiting
Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer
Breast NeoplasmsCardiovascular Diseases
St. Olavs Hospital1,600 enrolled2 locationsNCT02541435
Recruiting
Not Applicable
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
Breast Cancer
Region Skane1,350 enrolled26 locationsNCT05634889